Familial clustering of ovarian and endometrial cancers

被引:13
|
作者
Hemminki, K [1 ]
Granström, C
机构
[1] Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden
[2] Deutsch Krebsforschungszentrum, German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany
关键词
familial risk; sibling risk; seropapillary cystadenocarcinoma; endometrioid tumour;
D O I
10.1016/S0959-8049(03)00627-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Data on the association of ovarian cancer with other cancers in families are limited, and no data are available on the involvement of specific morphological types. The nationwide Swedish Family-Cancer Database on 10.2 million individuals and 19 175 invasive ovarian cancers was used to calculate standardised incidence ratios (SIRs) and 95% confidence intervals (CIs) for familial ovarian cancer in 0-66-year-old daughters when mothers or sisters were affected. The SIR for concordant ovarian cancers was increased. When the mother or sister had breast cancer, the SIRs were 1.21 and 1.48, respectively; when they had endometrial cancer, the SIRs were 1.45 and 2.53. Multiple myeloma in the mother was associated with a risk of ovarian cancer in the daughter. The risk of endometrioid ovarian cancer was 3.40 in the daughter when the mother presented with endometrial cancer. Our data show a strong familial coupling of ovarian and endometrial cancers, which appears to be specific to the endometrioid morphology. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:90 / 95
页数:6
相关论文
共 50 条
  • [11] PARP inhibitors and immunotherapy in ovarian and endometrial cancers
    Miller, Rowan E.
    Lewis, Amy J.
    Powell, Melanie E.
    BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1128):
  • [12] Hereditary female cancers: Breast, ovarian, and endometrial
    Tucker, J.
    Rizk, Botros
    MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2011, 16 (04) : 241 - 247
  • [13] Evidence of androgen action in endometrial and ovarian cancers
    Gibson, Douglas A.
    Simitsidellis, Ioannis
    Collins, Frances
    Saunders, Philippa T. K.
    ENDOCRINE-RELATED CANCER, 2014, 21 (04) : T203 - T218
  • [14] THE ROLE OF MELATONIN IN BREAST, OVARIAN AND ENDOMETRIAL CANCERS
    Jablonska, Karolina
    Zemla, Agata
    Dziegiel, Piotr
    POSTEPY BIOLOGII KOMORKI, 2011, 38 (01) : 177 - 194
  • [15] Chemoresistance and targeted therapies in ovarian and endometrial cancers
    Brasseur, Kevin
    Gevry, Nicolas
    Asselin, Eric
    ONCOTARGET, 2017, 8 (03) : 4008 - 4042
  • [16] The Role of Statins in the Prevention of Ovarian and Endometrial Cancers
    Zeleznik, Oana A.
    Irvin, Sarah R.
    Samimi, Goli
    Trabert, Britton
    CANCER PREVENTION RESEARCH, 2023, 16 (04) : 191 - 198
  • [17] Survival and prognostic factors in patients with synchronous ovarian and endometrial cancers and endometrial cancers metastatic to the ovaries
    Ayhan, A
    Guvenal, T
    Coskun, F
    Basaran, M
    Salman, MC
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2003, 24 (02) : 171 - 174
  • [18] Familial Ovarian Cancer Clusters with Other Cancers
    Guoqiao Zheng
    Hongyao Yu
    Anna Kanerva
    Asta Försti
    Kristina Sundquist
    Kari Hemminki
    Scientific Reports, 8
  • [19] Familial Ovarian Cancer Clusters with Other Cancers
    Zheng, Guoqiao
    Yu, Hongyao
    Kanerva, Anna
    Foersti, Asta
    Sundquist, Kristina
    Hemminki, Kari
    SCIENTIFIC REPORTS, 2018, 8
  • [20] TARGETING DNA REPAIR DEFICIENCY IN OVARIAN AND ENDOMETRIAL CANCERS
    Kaye, S. B.
    ANNALS OF ONCOLOGY, 2012, 23 : 40 - 40